Search

Author/Creator Bitman, Bojena

2. A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer. Issue 20 (5th August 2020)

Authors:
Zhang, Tian; Harrison, Michael R.; O'Donnell, Peter H.; Alva, Ajjai S.; Hahn, Noah M.; Appleman, Leonard J.; Cetnar, Jeremy; Burke, John M.; Fleming, Mark T.; Milowsky, Matthew I.; Mortazavi, Amir; Shore, Neal; Sonpavde, Guru P.; Schmidt, Emmett V.; Bitman, Bojena; Munugalavadla, Veerendra; Izumi...
Journal:
Cancer
Issue:
Volume 126:Issue 20(2020)
Page Start:
4485
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Impact of Etanercept on Work and Activity Impairment in Employed Moderate to Severe Rheumatoid Arthritis Patients in the United States. Issue 10 (24th September 2013)

Authors:
Hone, Devon; Cheng, Annie; Watson, Crystal; Huang, Baisong; Bitman, Bojena; Huang, Xing‐Yue; Gandra, Shravanthi R.
Journal:
Arthritis care & research
Issue:
Volume 65:Issue 10(2013:Oct.)
Page Start:
1564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial. Issue 2 (13th October 2011)

Authors:
Curtis, Jeffrey R; Yang, Shuo; Chen, Lang; Park, Grace S; Bitman, Bojena; Wang, Brian; Navarro-Millan, Iris; Kavanaugh, Arthur
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71:Issue 2(2012)
Page Start:
206
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗